[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Krüger et al., 2017 - Google Patents

Structure-based design of non-natural macrocyclic peptides that inhibit protein–protein interactions

Krüger et al., 2017

View PDF
Document ID
16700085779288861192
Author
Krüger D
Glas A
Bier D
Pospiech N
Wallraven K
Dietrich L
Ottmann C
Koch O
Hennig S
Grossmann T
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Macrocyclic peptides can interfere with challenging biomolecular targets including protein– protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle …
Continue reading at pubs.acs.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation

Similar Documents

Publication Publication Date Title
Krüger et al. Structure-based design of non-natural macrocyclic peptides that inhibit protein–protein interactions
Karatas et al. Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)–mixed lineage leukemia (MLL) protein–protein interaction
Stevers et al. A thermodynamic model for multivalency in 14-3-3 protein–protein interactions
Michelsen et al. Ordering of the N-terminus of human MDM2 by small molecule inhibitors
Nero et al. Oncogenic protein interfaces: small molecules, big challenges
Sun et al. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP)
Appavoo et al. Development of endocyclic control elements for peptide macrocycles
Kasperkiewicz et al. Design of a selective substrate and activity based probe for human neutrophil serine protease 4
Sijbesma et al. Identification of two secondary ligand binding sites in 14-3-3 proteins using fragment screening
Harper et al. Structure and catalytic regulatory function of ubiquitin specific protease 11 N-terminal and ubiquitin-like domains
Eildal et al. Probing the role of backbone hydrogen bonds in protein–peptide interactions by amide-to-ester mutations
Kale et al. Thiol-to-amine cyclization reaction enables screening of large libraries of macrocyclic compounds and the generation of sub-kilodalton ligands
Tan et al. Benzene probes in molecular dynamics simulations reveal novel binding sites for ligand design
Ahn et al. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1
Haberman et al. Discovery and development of cyclic peptide inhibitors of CIB1
Gambini et al. Design, synthesis, and structural characterization of lysine covalent BH3 peptides targeting Mcl-1
Yoo et al. Covalent targeting of Ras G12C by rationally designed peptidomimetics
Marchand et al. Discovery of inhibitors of four bromodomains by fragment-anchored ligand docking
Sarkar et al. Inhibiting matrix metalloproteinase-2 activation by perturbing protein–protein interactions using a cyclic peptide
Wu et al. Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Buyanova et al. Discovery of a bicyclic peptidyl pan-Ras inhibitor
Huang et al. A water-based mechanism of specificity and resistance for lapatinib with ErbB family kinases
Vulpetti et al. Structure-based library design and fragment screening for the identification of reversible complement factor D protease inhibitors
Salwiczek et al. Position‐Dependent Effects of Fluorinated Amino Acids on the Hydrophobic Core Formation of a Heterodimeric Coiled Coil
Krzyzanowski et al. Development of macrocyclic PRMT5–adaptor protein interaction inhibitors